Recursion Pharmaceuticals (RXRX) Earnings Date & Reports
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RXRX is expected to report earnings to fall 7.92% to -48 cents per share on May 07
Q1'25
Est.
$-0.49
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.03
The last earnings report on February 28 showed earnings per share of -52 cents, missing the estimate of -40 cents. With 10.77M shares outstanding, the current market capitalization sits at 2.05B.